Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Government & Policy Articles
Popular Government & Policy Articles
Highly Recommended Government & Policy Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
FDA’s Bad Ad Program
Billions of dollars per year are spent on patient-targeted drug advertisements.
The Food and Drug Administration (FDA) has launched a "Bad Ad Program," an outreach effort aimed at educating healthcare providers and urging them to report misleading drug advertisements. The Division of Drug Marketing, Advertising, and Communications (DDMAC), in the FDA's Center for Drug Evaluation and Research, administers the program.
The program will help healthcare providers recognize misleading drug promotion and provide them with a simple way to report back to the agency.
About $4 billion out of a $20 billion advertising budget goes toward patient-targeted advertisements. Some drug industry critics feel that TV drug ads emphasize the benefits of the medication and minimize the risks.
According to FDA regulations:
Prescription drug advertising must:
- Be accurate
- Balance the risk and benefit information
- Be consistent with the prescribing information approved by FDA
- Only include information that is supported by strong evidence from clinical studies
What types of promotion does DDMAC regulate?
- Sales representative presentations
- Speaker program presentations
- TV and radio advertisements
- All written or printed prescription drug promotional materials
DDMAC does not regulate promotion of:
- Over-the-Counter Drugs
- Dietary Supplements
- Medical Devices
Common Violations:
- Omitting or downplaying of risk
- Overstating the effectiveness
- Promoting off-label, or unapproved, uses
- Misleading drug comparisons
As part of its new program, FDA will offer doctors training at medical conferences to help spot misleading ads. They can report advertising violations anonymously by e-mailing badad@fda.gov or calling 877-RX-DDMAC.
* * *
Sources:
The FDA's Bad Ad Program: http://www.fda.gov/badad
Categories: Food, Government & Policy, Health Care, Medications, Pre-Diabetes, Type 1 Issues, Type 2 Issues
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...